This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Wall Street Analysts Think Salesforce.com (CRM) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Salesforce.com (CRM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) concluded the recent trading session at $339.11, signifying a -0.85% move from its prior day's close.
Docusign Stock Rises 20% in a Month: Should You Hold or Fold?
by Shuvra Shankar Dey
With DOCU shares witnessing a substantial surge, it's crucial to evaluate the stock's current position and its investment appeal.
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Should First Trust Dow 30 Equal Weight ETF (EDOW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EDOW
Salesforce.com (CRM) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Salesforce.com (CRM) reachead $322.25 at the closing of the latest trading day, reflecting a -0.93% change compared to its last close.
Reasons Why You Should Hold DocuSign Stock in Your Portfolio
by Zacks Equity Research
DOCU is experiencing a rise in customer demand for eSignature and benefiting from adopting a subscription model.
Workday Gains 17% in the Past Year: Reason to Buy WDAY Stock?
by Supriyo Bose
With solid fundamentals and healthy revenue-generating potential driven by robust demand trends, WDAY appears to be a solid investment proposition.
Five9 Collaborates With ServiceNow: Should Investors Buy the Stock?
by Zacks Equity Research
FIVN's collaboration with ServiceNow to integrate a comprehensive AI-empowered solution may bode well for the stock.
OptimizeRx Corp. (OPRX) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
OptimizeRx (OPRX) delivered earnings and revenue surprises of 100% and 14.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Netflix, Salesforce, Cisco and BK Technologies
by Zacks Equity Research
Netflix, Salesforce, Cisco and BK Technologies are included in this Analyst Blog.
Salesforce.com (CRM) Stock Moves -0.17%: What You Should Know
by Zacks Equity Research
Salesforce.com (CRM) reachead $341.15 at the closing of the latest trading day, reflecting a -0.17% change compared to its last close.
Top Stock Reports for Netflix, Salesforce & Cisco
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), Salesforce, Inc. (CRM) and Cisco Systems, Inc. (CSCO), as well as a micro-cap stock, BK Technologies Corporation (BKTI).
Salesforce.com (CRM) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Salesforce.com (CRM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
The Zacks Analyst Blog NVIDIA, Amazon, Visa and Salesforce
by Zacks Equity Research
NVIDIA, Amazon, Visa and Salesforce are included in this Analyst Blog.
4 Stocks to Gain as Dow Roars Past 44,000 for the First Time
by Ritujay Ghosh
Stocks like NVDA, AMZN, V and CRM will benefit from the Dow's ongoing rally.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Salesforce Stock Soars 16.1% in Six Months: What Should Investors Do?
by Anirudha Bhagat
With robust AI expansion, strategic acquisitions and solid market position, Salesforce stock shows potential.
Rigetti Set to Report Q3 Earnings: Buy, Sell or Hold the Stock?
by Nilanshi Mukherjee
RGTI's third-quarter 2024 performance is expected to have benefited from advancements in quantum computing technology and expanded global partnerships.
Salesforce.com (CRM) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the closing of the recent trading day, Salesforce.com (CRM) stood at $298.01, denoting a +1.12% change from the preceding trading day.
Will Salesforce.com (CRM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Salesforce.com (CRM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce.com (CRM) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Salesforce.com (CRM) closed at $293.77 in the latest trading session, marking a +1.14% move from the prior day.
Should You Bet on Wide Moat Stocks & ETFs Now?
by Sanghamitra Saha
The S&P 500 index has significant concentration risks. If you are worried about it, you can try quality investing like moat stocks and ETFs.